Lataa...

Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma

Relapsed/refractory diffuse large B-cell lymphoma (DLBCL) is highly heterogeneous and current trials are investigating new approaches to improve outcomes. Limited data on response endpoints can confound estimation of a treatment effect when designing studies of novel agents in this setting, which ca...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Wang, Ling, Lam, Hung, Shou, Yaping, Galaznik, Aaron
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2019
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524929/
https://ncbi.nlm.nih.gov/pubmed/31143374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26904
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!